![]() | ![]() |
Formats:
|
||||||||||||||||||||||||||
Copyright © 2007 by The American Society for Cell Biology Function of the Caenorhabditis elegans ABC Transporter PGP-2 in the Biogenesis of a Lysosome-related Fat Storage Organelle *Department of Biology and †Program in Biochemistry and Molecular Biology, Lewis and Clark College, Portland, OR 97219; and §Institute of Biological Chemistry, Washington State University, Pullman, WA 99164 Sandra Lemmon, Monitoring Editor Corresponding author.Address correspondence to: Greg J. Hermann (Email: hermann/at/lclark.edu) ‡ These authors contributed equally to this work.Received August 7, 2006; Revised December 19, 2006; Accepted December 22, 2006. This article has been cited by other articles in PMC.Abstract Caenorhabditis elegans gut granules are intestine specific lysosome-related organelles with birefringent and autofluorescent contents. We identified pgp-2, which encodes an ABC transporter, in screens for genes required for the proper formation of gut granules. pgp-2(−) embryos mislocalize birefringent material into the intestinal lumen and are lacking in acidified intestinal V-ATPase–containing compartments. Adults without pgp-2(+) function similarly lack organelles with gut granule characteristics. These cellular phenotypes indicate that pgp-2(−) animals are defective in gut granule biogenesis. Double mutant analysis suggests that pgp-2(+) functions in parallel with the AP-3 adaptor complex during gut granule formation. We find that pgp-2 is expressed in the intestine where it functions in gut granule biogenesis and that PGP-2 localizes to the gut granule membrane. These results support a direct role of an ABC transporter in regulating lysosome biogenesis. Previously, pgp-2(+) activity has been shown to be necessary for the accumulation of Nile Red–stained fat in C. elegans. We show that gut granules are sites of fat storage in C. elegans embryos and adults. Notably, levels of triacylglycerides are relatively normal in animals defective in the formation of gut granules. Our results provide an explanation for the loss of Nile Red–stained fat in pgp-2(−) animals as well as insight into the specialized function of this lysosome-related organelle. INTRODUCTION Lysosomes are membrane bound terminal endocytic compartments characterized by an acidic luminal pH and the activity of acid hydrolases (Kornfeld and Mellman, 1989 ). Specialized, cell type–specific compartments with lysosomal characteristics comprise a functionally diverse group of compartments known as lysosome-related organelles (Dell'Angelica et al., 2000 ). Lysosome-related organelle functions include the formation and storage of pigment (mammalian melanosomes and Drosophila pigment granules; Spritz, 1999 ; Raposo and Marks, 2002 ), the regulation of platelet aggregation (platelet dense granules; King and Reed, 2002 ), and the biogenesis of lung surfactant (lamellar bodies; Weaver et al., 2002 ).The human diseases Hermansky-Pudlak, Chediak-Higashi, and Griscelli syndromes result from dysfunctional lysosome-related organelles (Stinchcombe et al., 2004 ). Hermansky- Pudlak syndrome (HPS) is associated with the abnormal biogenesis of lysosome-related organelles including melanosomes and platelet-dense granules, which is manifested in partial albinism and impaired blood clotting (Huizing et al., 2002 ; Li et al., 2004 ). Mutations in eight different human genes are known to cause HPS, and at least seven additional genes are associated with HPS-like phenotypes in rodents (Wei, 2006 ). HPS genes encode Rab38 and subunits of the AP-3, HOPS, and BLOC-1, -2, and -3 complexes (Dell'Angelica, 2004 ; Di Pietro and Dell'Angelica, 2005 ). These proteins function in the sorting and transport of proteins to lysosomes and lysosome-related organelles.The intestinal cells of the nematode Caenorhabditis elegans contain gut granules, cell type–specific compartments that have been proposed to be lysosome-related organelles (Clokey and Jacobson, 1986 ; Hermann et al., 2005 ). Gut granules are acidified (Clokey and Jacobson, 1986 ), contain the vacuolar H+-ATPase (V-ATPase; Hermann et al., 2005 ), and act as terminal endocytic compartments (Clokey and Jacobson, 1986 ; Bossinger and Schierenberg, 1996 ). Gut granules are distinguished from other lysosomes in C. elegans by their birefringent (Laufer et al., 1980 ) and autofluorescent (Babu, 1974 ) contents. The biogenesis of gut granules requires C. elegans genes encoding homologues of Rab38 and subunits of the AP-3 and HOPS complexes (Hermann et al., 2005 ). Animals with mutations in these genes show a Glo (gut granule loss) phenotype characterized by loss and/or mislocalization of birefringent material into the embryonic intestinal lumen and/or the loss of adult autofluorescent gut granules.Disrupting the function of the ABC transporter PGP-2 results in the loss of acidified compartments (Nunes et al., 2005 ) and fat (Ashrafi et al., 2003 ; Nunes et al., 2005 ) in adult C. elegans intestinal cells. The function of pgp-2 in gut granule biogenesis and whether this might explain defects in fat storage exhibited by pgp-2(−) animals has not been investigated. In screens for Glo mutants we identified a gene glo-5 that we show is identical to pgp-2. Here we show that pgp-2 functions directly in gut granule biogenesis, likely in parallel to AP-3, and that gut granules are sites of fat storage in C. elegans.MATERIALS AND METHODS Strains, Alleles, and Genetics N2 was used as the wild-type strain. All strains were grown at 22°C and cultured as described (Brenner, 1974 ). References for mutant alleles are available at www.wormbase.org and are listed by chromosome: linkage group I (LGI): apt-6(ok429), dpy-5(e61), pgp-2(gk114), pgp-2(kx34), pgp-2(kx48), pgp-2(kx55), pgp-2(kx67); LGII: rrf-3(pk1426); LGV: glo-4(ok623); LGX: apt-7(tm920), glo-1(zu437); LG unknown: bIs33[rme-8::gfp] (Zhang et al., 2001 ), pwIs50[lmp-1::gfp] (Treusch et al., 2004 ), pwIs87[vha-6::rme-1::gfp] (Hermann et al., 2005 ), pwIs72[vha-6::rab-5::gfp] (Hermann et al., 2005 ); extrachromosomal: kxEx9[glo-1::gfp] (Hermann et al., 2005 ), kxEx41 [glo-3::gfp] (Rabbitts and Hermann, unpublished results).glo-5 alleles were isolated following ethylmethane sulfonate or ethyl nitroso urea-mutagenesis using the method described by Hermann et al. (2005) . Single nucleotide polymorphism mapping with CB4856 (Davis et al., 2005 ) placed kx34, kx48, and kx67 on LGI between −6 and +5. kx48 and kx55 mapped to the dpy-5 unc-13 genetic interval. Standard genetic tests placed kx34, kx48, kx55, and kx67 into the glo-5 complementation group. The Glo phenotypes of all glo-5 alleles were found to be recessive and expressed zygotically. kx48 was backcrossed two to five times to N2 and kx55 was backcrossed two times to N2 before being used for phenotypic studies.Double mutants were constructed by mating unmarked Glo mutants into dpy-5(e61) marked kx48 or kx55 mutants to generate transheterozygotes. We isolated Glo non-Dpy adult progeny from the transheterozygotes. Resulting homozygous double mutants were identified by their Dpy phenotype. In all cases at least two independently generated double mutant lines were analyzed and found to exhibit the same phenotype. The linked dpy-5(e61) mutation did not alter the Glo phenotypes. RNA interference (RNAi) using clones from a genomic library (Kamath et al., 2003 ) was carried out as described in the RNAi-sensitive rrf-3(pk1426) background (Simmer et al., 2002 ).Microscopy A Zeiss Axioskop II plus microscope (Thornwood, NY) equipped with DIC, polarization, and fluorescence optics was used for all microscopic analysis. Images were captured with an Insight Spot QE 4.1 camera (Diagnostic Instruments, Sterling Heights, MI). Pretzel stages embryos were placed on slides with excess Escherichia coli or briefly chilled to 4°C to induce a paralyzed state before imaging. Larvae and adults were immobilized by mounting in 1× M9 containing 10 mM levamisole. Images used for phenotypic comparisons were always captured at the same exposure times, and brightness and contrast were adjusted identically. Birefringent intestinal material was visualized using polarization optics. Zeiss 9 (Ex:BP450–490; EmLP515) and Zeiss 15 (Ex:BP586/12; Em:LP590) filters were used to visualize autofluorescence. A custom (Ex:BP480/20; Em:BP530/20) filter was used to analyze the colocalization of green fluorescent protein (GFP) signals and birefringent material in living embryos. Staining of adult gut granules with Lysotracker Red (Molecular Probes, Eugene, OR) and embryonic and adult gut granules with acridine orange (Sigma, St. Louis, MO) were performed as described (Hermann et al., 2005 ). The staining of all lysosomal dyes was analyzed using a Zeiss 15 fluorescence filter set. Endocytosis was monitored by staining with tetramethylrhodamine B isothiocyanate (TRITC)-BSA (Sigma) using the procedure described by Hermann et al., 2005 . Fat stores were stained by growing embryo/L1 stage animals to adulthood on seeded nematode growth media (NGM) plates to which Nile Red (Molecular Probes, Eugene, OR) had been added to a final concentration of approximately 50 ng/ml (Ashrafi et al., 2003 ) or BODIPY 493/503 (Molecular Probes) had been added to a final concentration of ~0.5 ng/ml. Adults and their progeny stained by Nile Red or BODIPY 493/503 were removed from plates and immediately scored. Zeiss 15 and a custom (Ex:BP480/20; Em:BP530/20) filter were used to analyze the colocalization of Nile Red with autofluorescence and GLO-1::GFP. All analysis of GFP in living embryos was carried out using a custom (Ex:BP480/20; Em:BP530/20) filter. Embryos were fixed and stained with mouse 3E6 anti-GFP (Qbiogene, Carlsbad, CA) and affinity-purified rabbit anti-FUS-1 (Kontani et al., 2005 ), anti-VHA-11 (Oka and Futai, 2000 ), anti-VPS-27 (Roudier et al., 2005 ), and anti-PGP-2 (this work) antisera as described (Leung et al., 1999 ).Lipid Analysis Embryos were isolated from adult worms and grown at 22°C on NGM plates with an excess of food until the majority of the population reached young adulthood, indicated by the presence of 1–3 embryos in the uterus. Worms were washed off the plates with 1× M9 and rinsed four times with 1× M9 by letting the worms settle and discarding the supernatant. After the rinses, the worms were spun down in a microfuge tube and as much of the 1× M9 as possible was removed from the final pellet (>400 mg), which was immediately flash-frozen in liquid N2 and stored at −70°C. Total lipids were extracted from worm pellets, separated using thin-layer chromatography (TLC), and quantified using gas chromatography as described (Brock et al., 2006 ).Cloning glo-5 glo-5 mapped to the dpy-5 unc-13 interval of LGI. The Glo phenotypes of candidate genes located in this interval were assessed using existing mutants or with RNAi. pgp-2(gk114) embryos and adults exhibited a Glo phenotype. pgp-2(RNAi) in the rrf-3(pk1246) background exhibited a strong adult and a weak embryonic Glo phenotype. Three of four stable transmitting glo-5(kx48) lines injected with cosmid C34G6 at 10 ng/μl and the coinjection marker pRF4[Rol-6D] at 100 ng/μl were GLO(+). A 17.3-kb fragment extending from 7.6 kb upstream to 625 base pairs downstream of the pgp-2 coding sequence was PCR amplified using C34G6 as a template with primers P442 5′CGGATGAGAAGGGAGGGATCTTAGAAG3′ and P460 5′TCGTCGATGAAAACAATGTTACCTTCG3′. All PCR reactions used in these studies utilized Phusion high fidelity DNA polymerase (New England Biolabs, Beverly, MA). The PCR product was coinjected at 10 ng/μl with pRF4[Rol-6D] at 100 ng/μl. Four of four independently derived transmitting lines were GLO(+). The sequence of mutant alleles was obtained by PCR amplifying the pgp-2 coding sequences from glo-5(−) mutants. Amplifications and DNA sequencing (OHSU Core Facility) were performed in duplicate. The pgp-2 cDNA was amplified from total RNA isolated using Trizol/chloroform extraction. cDNA was generated using d(T)20 and random hexamers with Superscript III (Invitrogen, Carlsbad, CA). An SL1 primer and a primer specific for the 3′ end of pgp-2 were used to amplify the full-length cDNA which was sequenced and found to contain an alternative exon 1 (GenBank accession no. EF205592) when compared with the pgp-2 cDNA predicted by Genefinder (Wormbase160). Generation of pgp-2::gfp, PGP-2::GFP, and PGP-2 ATPase Mutants The transcriptional reporter pgp-2::gfp was constructed using PCR fusion (Hobert, 2002 ). A 7.6-kb sequence 5′ of the new predicted translational start of pgp-2 was amplified using P441 5′CTGTTCGCCAAGCACCCTTCTGAAAAG3′ and P485 5′CAGTGAAAAGTTCTTCTCCTTTACTCATTGAAATGAAGATCTGAACAGAAAAG3′. GFP-NLS was amplified from pPD95.67 using P269 5′ATGAGTAAAGGAGAAGAACTTTTCACTG3′ and P266 5′AAGGGCCCGTACGGCCGACTAGTAGG3′. These two PCR products were fused using P442 and P267 5′GGAAACAGTTATGTTTGGTATATTGGG3′ as described (Hobert, 2002 ). The resulting pgp-2::gfp product was coinjected at 5 ng/μl with pRF4[Rol-6D] at 100 ng/μl into wild type. kxEx74[pgp-2::gfp;Rol-6D] was used for the analysis in this article, and two other independently derived lines showed the same GFP expression pattern.The translational reporter PGP-2::GFP was constructed by amplifying the full-length pgp-2 cDNA with P453 5′GGGGACAACTTTGTACAAGAAAGTGTATTGACTTTCGACAATCCTCTGCG3′ and P482 5′GGGGACAACTTTGTACAAAAAAGTTGTGGGAAAAGACACGGAGAAAACTCC3′ and Gateway (Invitrogen) cloning the resulting product using a BP reaction into pDONR221. All transformations of plasmids containing pgp-2 were carried out using CopyCutter EPI400 (Epicenter, Madison, WI) E. coli. The resulting pLKS2 plasmid was fully sequenced to ensure a lack of PCR-generated mutations. pgp-2 was Gateway cloned using an LR reaction into a VHA-6(promoter)::GFP::GTWYB(EcoRI) vector (Chen et al., 2006 ). The resulting plasmid pLKS4 contains an N-terminal fusion of gfp to pgp-2 whose expression is regulated by the vha-6 promoter. The addition of 26 C-terminal amino acids derived from flanking 3′ vector sequences disrupted the function of PGP-2::GFP (not shown). To generate a rescuing PGP-2::GFP construct, PCR fusion was used to introduce a stop codon and the unc-54 3′ untranslated region (UTR) at the end of the pgp-2 coding sequence. vha-6(promoter)::gfp::pgp-2 was amplified from pLKS4 using P504 5′AAATGAAATAAGCTTGCATGCCTGCAG3′ and P506 5′CCGGCGCTCAGTTGGAATTCTACGATTATTGACTTTCGACAATCCTCTGCG3′ and the unc-54 3′ UTR was amplified from pPD95.75 using P507 5′TCGTAGAATTCCAACTGAGCGCCGG3′ and P266. The resulting vha-6(promoter)::gfp::pgp- 2::unc-54 3′ UTR product was coinjected at 5 ng/μl with pRF4[Rol-6D] at 100 ng/μl into pgp-2(kx48) and wild type. pgp-2(kx48); kxEx93[PGP-2::GFP;Rol-6D] was used for the analysis presented in this article, and 13 other independently derived lines showed the same GFP expression pattern. Eleven of fourteen lines were GLO(+). pgp-2(kx48); kxEx93[PGP-2::GFP;Rol-6D] showed wild-type patterns of Nile Red–stained fat and acridine orange–stained acidified compartments and was used to determine the cellular localization of PGP-2::GFP in adults. kxEx98[PGP- 2::GFP;Rol-6D] was used to determine the cellular localization of PGP-2::GFP in embryos.To express PGP-2::GFP under the control of unc-119 regulatory sequences (Maduro and Pilgrim, 1995 ), we performed a triple PCR fusion. The vha-6(promoter)::gfp::pgp-2 sequence was amplified with P504 and P506 from pLKS4 and the unc-54 3′UTR was amplified from pPD95.75 with P507 and P266. The resulting fragments were fused using P269 and P266. gfp::pgp-2::unc-54 3′UTR was fused with the unc-119 promoter amplified from genomic DNA with P495 5′TTTTCCCTTTCCCTCTTGGGGAAAACGGG3′ and P496 5′CAGTGAAAAGTTCTTCTCCTTTACTCATATATGCTGTTGTAGCTGAAAATTTTGGGG3′ using P508 5′TCGAAGACAAACTTTTCAAAAAATTG3′ and P267. The resulting unc-119(promoter)::gfp::pgp-2::unc-54 3′ UTR product was coinjected at 5 ng/μl with pRF4[Rol-6D] at 100 ng/μl into pgp-2(kx48). unc- 119(promoter)::gfp::pgp-2::unc-54 3′ UTR was expressed throughout the nervous system and did not rescue the loss of adult autofluorescence in 3/3 independently derived lines. pgp-2(kx48); kxEx100[unc-119::PGP-2::GFP;Rol-6D] was scored for rescue of adult Nile Red–stained fat and acridine orange–stained acidified compartments.To alter the ATPase domains of PGP-2, site-directed mutagenesis with Quickchange II (Stratagene, La Jolla, CA) with primers P501 5′GGTCGGTTCAAGTGGTTGTGGAAGATCAACAATTG3′ and P501R 5′CAATTGTTGATCTTCCACAACCACTTGAACCGACC3′ were used to change Lys440 to Arg and primers P502 5′GGCACTCAGGATGTGGAAGATCTACAATTATGGG3′ and P502R 5′CCCATAATTGTAGATCTTCCACATCCTGAGTGCC3′ were used to change Lys1069 to Arg in plasmid pLKS4 to generate two plasmids pSK7 and pSK8, respectively. The P502 and P502R primers were used to change Lys1069 to Arg in pSK7 resulting in the double ATPase mutant (pSK9). The coding sequences of pgp-2 and gfp were fully sequenced to verify no other mutations were introduced during mutagenesis. We performed the same PCR fusion steps as used in the generation of vha-6(promoter)::gfp::pgp-2::unc-54 3′ UTR to construct vha-6(promoter)::gfp::pgp-2(K440R)::unc-54 3′ UTR, vha- 6(promoter)::gfp::pgp-2(K1069R)::unc-54 3′ UTR, and vha-6(promoter)::gfp::pgp-2(K440R; K1069R)::unc-54 3′ UTR. These were each coinjected at 1–5 ng/μl with pRF4 [Rol-6D] at 100 ng/μl into pgp-2(kx48) and wild type. The resulting transmitting lines with comparable levels of PGP-2::GFP expression were characterized. pgp-2(kx48); kxEx102 [PGP-2(K440R)::GFP;Rol-6D] was used for the analysis presented in this article, and 2/2 other independently derived lines showed similar partial rescue of autofluorescence. pgp-2(kx48); kxEx102 was scored for rescue of Nile Red–stained fat and acridine orange–stained acidified compartments and pgp-2(+); kxEx104 [PGP-2(K440R)::GFP;Rol-6D] was used to determine the cellular localization of PGP-2(K440R)::GFP in adults. pgp-2(kx48); kxEx103 [PGP-2(K1069R)::GFP;Rol-6D] was used for the analysis presented in this article, and 3/3 other independently derived lines showed similar partial rescue of autofluorescence. pgp-2(kx48); kxEx103 was scored for rescue of Nile Red–stained fat and acridine orange–stained acidified compartments, and pgp-2(+); kxEx105 [PGP-2(K1069R)::GFP;Rol-6D] was used to determine the cellular localization of PGP-2(K1069R)::GFP in adults. pgp-2(kx48); kxEx115 [PGP-2(K440R; K1069R)::GFP;Rol-6D] was used for the analysis presented in this article, and one other independently derived lines showed similar partial rescue of autofluorescence and Nile Red staining. pgp-2(kx48);kxEx115 was scored for rescue of Nile Red–stained fat and acridine orange–stained acidified compartments, and pgp-2(+); kxEx117 [PGP-2(K440R; K1069R)::GFP;Rol-6D] was used to determine the cellular localization of PGP-2(K440R; K1069R)::GFP in adults. PGP-2 Antibodies Affinity-purified antibodies recognizing PGP-2 were generated by Bethyl Laboratories (Montgomery, TX). Peptides corresponding to amino 1MGKDTEKTPLLLKS-cys14 and carboxy 1259cys-YQKFsETQRIVESQ1272 (C1263S) terminal PGP-2 sequences were synthesized, coupled to KLH, and used for immunization. Agarose-linked peptides were used to affinity-purify antibodies. The specificity of each antisera was confirmed using pgp-2(kx48) Arg466-stop embryos. The anti-carboxy terminal PGP-2 antisera was used in the studies presented here; however, identical results were observed using the anti-amino terminal PGP-2 antisera. RESULTS Identification of glo-5 as pgp-2 In genetic screens for Glo mutants we identified four alleles of a gene we named glo-5 (see Materials and Methods) that exhibited mislocalization of birefringent material into the embryonic intestinal lumen and contained greatly reduced numbers of birefringent and autofluorescent gut granules. We mapped glo-5 to a 2.07 map unit region of the genome defined by dpy-5 and unc-13. Using a candidate gene approach, we found that pgp-2(gk114) and pgp-2(RNAi) animals exhibited a Glo phenotype very similar to glo-5(kx48) and glo-5(kx55) (Table 1). pgp-2(gk114) did not complement the Glo phenotypes of glo-5(kx34), glo-5(kx48), or glo-5(kx55). The genomic cosmid C34G6, containing pgp-2, and the pgp-2 coding sequence amplified from wild type, rescued the Glo phenotype of glo-5(kx48) (not shown). DNA sequencing showed that each glo-5 allele, kx34, kx48, kx55, and kx67, had a mutation that altered the predicted coding sequence of pgp-2 (Figure 1
pgp-2 encodes a member of the ABCB subfamily of ABC transporters. The best understood ABCB protein is human P-glycoprotein (Pgp) encoded by the MDR1 gene, which plays a significant role in tumor cell resistance to anticancer agents (Sheps et al., 2004 ). Similar to other ABCB proteins, PGP-2 is predicted to have a domain structure composed of six transmembrane (TM)-spanning domains preceding a cytoplasmic ATPase domain, followed by another 6-TM-spanning domains preceding a cytoplasmic ATPase domain (Holland et al., 2003 ; Figure 1 ). The kx48 allele is predicted to truncate the PGP-2 protein between the Walker A and Walker B motifs in the first ATPase domain (Figure 1
pgp-2 Functions in Gut Granule Biogenesis Wild-type gut granules contain birefringent material from the bean (Hermann et al., 2005 ) through pretzel-stages of embryogenesis (Table 1 and Figure 2 ). Body elongation begins at the bean stage, transforming the ball of embryonic cells into a worm that appears pretzel-like in the eggshell. Between bean and pretzel, the stages of development are described by the length of the embryo relative to the length of the eggshell. Bean-to-hatching stage pgp-2(−) embryos contained substantially reduced numbers of birefringent granules within their intestinal cells when compared with wild type (Table 1 and Figure 2
We determined whether pgp-2 was necessary for the biogenesis of gut granules, or just for the formation and localization of their birefringent contents. In wild-type embryos, gut granules are acidified and are characterized by the presence of the vacuolar H+-ATPase (V-ATPase) and the Rab GTPase GLO-1 (Hermann et al., 2005 ). In comparison to wild type (Figure 3 ) that localizes to gut granules in wild-type embryos (Hermann et al., 2005 ; Figure 3 ), was analyzed (Figure 3 ). GLO-1::GFP localized to gut granules in wild-type embryos (Hermann et al., 2005 ; Figure 3
To better understand the role of pgp-2 in gut granule biogenesis, we investigated the subcellular localization of birefringent material in pgp-2(−) embryonic intestinal cells. In wild-type 1.5-fold– and pretzel-stage embryos (Figure 3 ) for their presence around birefringent puncta. In wild-type pretzel-stage embryos, birefringent material was rarely found within RAB-5::GFP (1%, n = 142), RAB-7::GFP (0.5%, n = 227), or LMP-1::GFP (3%, n = 245) containing organelles. In pgp-2(−) embryonic intestinal cells, birefringent material did not colocalize with RAB-5::GFP (not shown). However, a minor proportion of birefringent puncta in pgp-2(−) pretzel-stage embryos colocalized with LMP-1::GFP (20%, n = 55) and RAB-7::GFP (12%, n = 57; not shown). Although there are GLO-1::GFP puncta in pgp-2(−) embryos (Figure 3 ) that localizes to the gut granule membrane (Rabbitts and Hermann, unpublished results). In wild-type 1.5-fold– and pretzel-stage embryos, 80% (n = 79) and 76% (n = 137) of birefringent puncta colocalized with GLO-3::GFP (not shown), respectively. In contrast, only 7% (n = 55) of birefringent puncta in pgp-2(−) 1.5-fold–stage embryos and 12% (n = 51) of birefringent puncta in pgp-2(−) pretzel-stage embryos colocalized with GLO-3::GFP (not shown).To determine whether the formation of birefringent puncta in pgp-2(−) embryonic intestinal cells required the activity of genes that function in gut granule biogenesis, we generated double mutants between pgp-2 and glo-1 or glo-4. glo-4 encodes a putative guanine nucleotide exchange factor for GLO-1, and glo-4(−) and glo-1(−) embryos lack birefringent gut granules (Hermann et al., 2005 ). We found that pgp-2(−); glo-1(−) and pgp-2(−); glo-4(−) mutants lacked embryonic birefringent granules (Table 1), indicating that glo-1 and glo-4 are necessary for the formation of birefringent organelles in pgp-2(−). Together these data indicate that the birefringent material in pgp-2(−) embryos is contained within endolysosomal compartments, possibly aberrantly formed gut granules.We examined whether pgp-2 was necessary for the formation of other endolysomal organelles in C. elegans embryos. In wild type, the early endosome-associated proteins RME-1::GFP (Grant et al., 2001 ), RAB-5::GFP (Chen et al., 2006 ), and VPS-27 (Roudier et al., 2005 ) were localized to punctate structures present throughout the cytoplasm or enriched near the apical surface of embryonic intestinal cells (Figure 3 ; Chen et al., 2006 ) is associated with the basolateral plasma membrane and what are likely endosomal compartments localized near the apical membrane (Figure 3 ) and glo-3 (Kokes and Hermann, unpublished results) mutants; however, the cellular basis of this effect is currently unknown. RME-8::GFP (Zhang et al., 2001 ) and RAB-7::GFP (Chen et al., 2006 ) localize to what are likely late endosomes in embryonic intestinal cells (Figure 3We next asked whether pgp-2 was necessary for the formation of gut granules in L4 and adult stage animals. At these stages, wild-type intestinal cells contain hundreds of gut granules characterized by their autofluorescent contents, acidity, and function as terminal endocytic compartments (Clokey and Jacobson, 1986 ; Figure 4 ). Together, these data suggest that the autofluorescent material in pgp-2(−) intestinal cells is contained within aberrantly formed gut granules. Consistent with this idea, we found that pgp-2(−); glo-1(−) and pgp-2(−); glo-4(−) adults lacked autofluorescent material in their intestinal cells (Table 1). We conclude that mutations in pgp-2 disrupt adult gut granule formation.
While this article was in preparation Nunes et al. (2005) similarly showed the lack of acidified compartments in pgp-2(−) adults. However, in contrast to our findings, pgp-2(−) animals were reported to be unable to internalize FITC-dextran. Possibly, low levels of endocytosed material were not apparent in the studies of Nunes et al. because of the presence of weakly autofluorescent organelles in pgp-2(−) that are visible with standard FITC filter sets (Figure 5The Role of ABCB Transporters in Gut Granule Biogenesis We examined whether any other transporters in the ABCB subfamily were necessary for gut granule biogenesis. The C. elegans genome encodes 24 members of the ABCB subfamily (Sheps et al., 2004 ). Fifteen ABCB transporters, denoted PGP, have a domain structure similar to PGP-2 (Figure 1 ), suggesting the possibility that haf-4 mediates transport across the gut granule membrane to facilitate the formation of birefringent material. Together, our analyses indicate that the ABCB subfamily of transporters do not play a general role in C. elegans gut granule biogenesis and suggest that PGP-2 uniquely functions in the formation of gut granules.pgp-2 Acts in Parallel to AP-3 The requirement of glo-1 and glo-4 in the generation of birefringent and autofluorescent material within pgp-2(−) intestinal cells (Table 1) strongly suggests that pathways for gut granule biogenesis are still functional in pgp-2(−) animals. To identify specific gut granule trafficking pathways that are acting in pgp-2(−) animals, we investigated the functional relationship between pgp-2 and AP-3 in the formation of the birefringent and autofluorescent material normally localized within the gut granule (Hermann et al., 2005 ). The C. elegans AP-3 adaptor complex is composed of four proteins, including the β3 and μ3 subunits encoded by apt-6 and apt-7 (Boehm and Bonifacino, 2001 ), respectively. The AP-3 complex mutants, like pgp-2(−), contained reduced numbers of birefringent granules and autofluorescent organelles (Table 1 and Figures 2 ). We found that pgp-2(kx48) apt-6(ok429), pgp-2(kx48); apt-7(tm920), and pgp-2(kx55); apt-7(tm920) double mutants always lacked birefringent and autofluorescent organelles (Table 1 and Figure 2Gut Granules Are Sites of Fat Storage in C. elegans pgp-2(+) activity has been implicated in regulating C. elegans adult fat storage. pgp-2(RNAi) (Ashrafi et al., 2003 ), pgp-2(gk114) (Nunes et al., 2005 ), and pgp-2(kx48) (Figure 5 ; McKay et al., 2003 ). Given the requirement of pgp-2(+) activity for both gut granule biogenesis and the formation of fat storage compartments in intestinal cells, we investigated whether gut granules are sites of fat storage. We examined L4/adult stage animals and found that Nile Red staining coincided with gut granule autofluorescence (Figure 5 ; Figures 5
If gut granules are sites of fat storage, then animals defective in their formation should have reduced numbers of Nile Red–stained compartments. Mutations in glo-1 and apt-7 resulted in adults that lacked Nile Red–stained compartments within their intestinal cells (Figure 5 To determine whether glo mutants contain reduced levels of fat, total lipids were extracted from wild-type and mutant animals, separated by TLC, and quantified by gas chromatography. Levels of triacylglycerides, which are likely the major form of stored fat in C. elegans (Ashrafi et al., 2003 ), were not obviously altered in pgp-2(−) and glo-1(−) relative to wild- type (Figure 5PGP-2 Is Expressed in the Intestine and Localized to the Gut Granule Membrane We investigated pgp-2 expression by using a gfp reporter expressed under the control of the pgp-2 promoter (pgp-2::gfp). Prior analysis has reported pgp-2::gfp expression in pharngeal and AWA neuronal cells; however, the design of pgp-2 reporter constructs used in prior studies was based on an incorrectly predicted first exon (Zhao et al., 2004 ; Nunes et al., 2005 ). Our cDNA analysis showed that exon 1 of pgp-2 is encoded 2.2 kb upstream of the predicted exon 1 (Wormbase WS160). We placed gfp under the control of a 7.6-kb sequence that extends from the predicted upstream gene C34G6.6 to the new predicted start codon of pgp-2. Embryonic expression of pgp-2::gfp was first seen in the daughters of the E blastomere (E2 stage), which generate the intestine (Figure 7
We analyzed the localization of PGP-2 with anti-PGP-2 antibodies and an amino terminally tagged PGP-2::GFP fusion expressed under the control of the intestinal specific vha-6 promoter (Oka et al., 2001 ; Pujol et al., 2001 ). The PGP-2::GFP fusion rescued the loss of autofluorescence, Nile Red–stained fat, and acridine orange–stained acidified compartments in pgp-2(kx48) (Figure 9 ) did not result in rescue of pgp-2(−) (Table 2). Intestinally expressed PGP-2::GFP was localized to prominent vesicular structures and the plasma membrane in embryos and adults (Figure 8Mutations in PGP-2 Predicted To Block ATPase Activity Disrupt Gut Granule Biogenesis We determined whether the hydrolytic activity of the two ATPase domains of pgp-2 is functionally important for gut granule formation. Structural studies suggest that the Walker A motif GX4GKS(S/T) interacts with the β and γ phosphates of ATP (Schneider and Hunke, 1998 ). Changing the lysine to arginine in the Walker A motif of ABC transporters disrupts ATP hydrolysis (Schneider and Hunke, 1998 ), and mutating the conserved lysine to arginine in one or both ATPase domains has been shown to disrupt the transport activity of P-glycoprotein (Azzaria et al., 1989 ), MDR3 (Urbatsch et al., 1998 ), and STE-6 (Berkower and Michaelis, 1991 ). The lysine residue in the Walker A motif of each or both ATPase domain of PGP-2 was changed to arginine by site directed mutagenesis (Figure 1DISCUSSION ABC Transporters in Lysosome Biogenesis We have shown that the ABC transporter PGP-2 plays an important role in lysosome-related organelle biogenesis in C. elegans. Gut granules are acidified, terminal endocytic, fat containing, lysosome-related organelles with birefringent and autofluorescent contents (Clokey and Jacobson, 1986 ; Hermann et al., 2005 , this work). Disrupting pgp-2(+) activity results in the partial mislocalization of birefringent material into the embryonic intestinal lumen (Figure 2 ; Mullins and Bonifacino, 2001 ). Indeed, the activity of three C. elegans genes encoding proteins implicated in vesicle trafficking (a Rab GTPase and two subunits of the AP-3 complex) result in the similar extracellular mislocalization of birefringent material (Hermann et al., 2005 ). Mutations in pgp-2 also lead to defects in the formation of acidified gut granules. In intestinal cells at the 1.5-fold stage, subunits of the V-ATPase are enriched on gut granule membranes (Oka and Futai, 2000 ; Hermann et al., 2005 ). Similarly staged pgp-2(−) embryos lacked detectable expression of two V-ATPase subunits and had greatly reduced numbers of acidified compartments in embryonic intestinal cells (Figure 3 , we found that pgp-2(−) adults lacked acidified intestinal organelles (Figure 4The gut granule biogenesis pathways involving the GLO-1 Rab GTPase and the AP-3 complex appear to be active in pgp-2(−) animals. Late-stage pgp-2(−) embryos still are able to generate a limited number of birefringent compartments that are acidified (Figure 3 Prior studies led to the proposal that pgp-2 functions in a subset of neuronal cells to specifically control acidification of intestinal organelles and that pgp-2(+) activity is not necessary for lysosomal biogenesis (Nunes et al., 2005 ). The conclusion that pgp-2 is expressed in a few chemosensory neurons and not in the intestine is based upon a reporter lacking the entire pgp-2 promoter. Our transcriptional reporter, which was designed based on experimental determination of the start of the pgp-2 coding sequence, indicates that pgp-2 is expressed in the intestine and not in chemosensory neurons (Figure 7 ) in pgp-2(−) animals (Nunes et al., 2005 ). However, current data indicate that LMP-1::GFP is not associated with embryonic or adult gut granules (Chen et al., 2006 and our unpublished observations); instead LMP-1::GFP may be present on other endosomal compartments such as conventional lysosomes that coexist with gut granules in intestinal cells. On the basis of our results we conclude that pgp-2 functions in intestinal cells to directly regulate the formation of gut granules.ATP hydrolysis by ABC transporters fuels the transport of substrates across a membrane (Higgins, 1992 ). The pgp-2(K440R), pgp-2(K1069R), and pgp-2(K440R; K1069R) mutations in the Walker A motifs of ATPase domain similarly disrupt the function of PGP-2 in gut granule formation (Figure 9 ), MDR3 (Urbatsch et al., 1998 ), and STE-6 (Berkower and Michaelis, 1991 ), that disrupt transport activity. These results strongly suggest that the role of PGP-2 in gut granule biogenesis actively involves its transporter activity.We propose that PGP-2 regulates membrane traffic involved in gut granule biogenesis by controlling the membrane composition of the gut granule where PGP-2 is localized (Figure 8 ). Presently, what PGP-2 could be transporting is a matter of speculation. However, proteins within an ABC subfamily have an evolutionarily conserved propensity to transport similar substrates (Holland et al., 2003 ). A number of ABCB subfamily proteins, of which PGP-2 is a member, transport lipids and sterols from the cytosolic to the lumenal or exoplasmic leaflet of cellular membranes (Pohl et al., 2005 ; van Meer et al., 2006 ). PGP-2 might therefore function to control lipid or sterol-based signals that regulate membrane trafficking by promoting their removal from the cytosolic leaflet of a cellular membrane (Downes et al., 2005 ; Maxfield and Tabas, 2005 ). Alternatively, PGP-2 mediated movement of lipids or sterols from the cytosolic to luminal leaflet of a membrane could modify its physical properties to mechanically regulate membrane trafficking (Graham, 2004 ; McMahon and Gallop, 2005 ). Intriguingly, members of the Drs2 family of P-type ATPases mediate the movement of lipids from the lumenal to the cytosolic leaflet of membranes and function in vesicle transport to lysosomes in yeast (Gall et al., 2002 ; Hua et al., 2002 ; Wicky et al., 2004 ). The identification and characterization of extragenic suppressors of pgp-2(−), which could identify genes whose activity counteracts pgp-2(+), would be a first step in discerning the molecular activity of PGP-2 in organelle biogenesis.Recently another ABC transporter has been directly implicated in endolysosomal organelle biogenesis. ABCA3 is a lamellar body–associated lipid transporter whose inactivation results in respiratory distress syndrome (Shulenin et al., 2004 ). RNAi-mediated knockdown of ABCA3 expression results in the loss of lamellar body–associated proteins from cells, suggestive of a defect in the biogenesis (Cheong et al., 2006 ) of this lysosome-related organelle (Weaver et al., 2002 ). Two other ABC transporters are implicated in trafficking through the endolysosomal pathway: MdrA1 in Dictyostelium localizes to endolysosomal membranes and mdrA1(−) cells show decreased rates of endocytosis (Brazill et al., 2001 ); and mutations in ABCA1 cause Tangier disease and result in increased rates of endocytosis (Zha et al., 2001 ). Presently at least nine mammalian ABC transporters, ABCA1 (Neufeld et al., 2004 ), ABCA2 (Zhou et al., 2001 ), ABCA3 (Yamano et al., 2001 ), ABCA5 (Kubo et al., 2005 ), ABCB1 (Rajagopal and Simon, 2003 ), ABCB9 (Zhang et al., 2000 ), ABCC1 (Rajagopal and Simon, 2003 ), ABCC4 (Jedlitschky et al., 2004 ), and ABCG2 (Rajagopal and Simon, 2003 ), are associated with late endosomes, lysosomes, or lysosome-related organelles. For most of these proteins it remains an open question whether they function in membrane trafficking and/or organelle biogenesis.Gut Granules as Sites of Fat Storage The studies presented here provide evidence that gut granules function as fat storage organelles in C. elegans adults and embryos. We found that two different lipid selective probes, Nile Red (Greenspan and Fowler, 1985 ; Greenspan et al., 1985 ) and BODIPY 493/503 (Gocze and Freeman, 1994 ), stained autofluorescent gut granules of adults (Figure 5 ) resulted in the loss or reduction of Nile Red staining in adult and embryonic intestinal cells and the mislocalization of Nile Red–stained fat into the embryonic intestinal lumen (Figures 5 identify four additional Glo genes, apt-6, glo-3, glo-4, and vps-16 (Hermann et al., 2005 ), as having loss of Nile Red–stained intestinal compartments. Notably, the vast majority of RNAi clones identified by Ashrafi et al. (2003) that cause reduced Nile Red staining in the intestine do not cause obvious defects in the formation of autofluorescent gut granules (our unpublished observations), suggesting that gut granules do not nonspecifically accumulate the Nile Red dye. We therefore conclude that fat storage in C. elegans is a specialized function of the gut granule and think it likely that the loss of Nile Red–stained fat exhibited by Glo mutants is a consequence of defects in properly forming gut granules.Despite lacking Nile Red staining in intestinal cells, glo mutations do not or only slightly alter the overall level of fat/triacylglycerides in the animal. pgp-2(−), and glo-1(−) contained wild-type amounts of fat, whereas apt-7(−) showed a slight decrease (Figure 5 ). Consistent with our findings, the glo mutants we analyzed develop similarly to wild type (Hermann et al., 2005 and data not shown). The lack of a pronounced decrease in fat levels when the activity of the glo genes is disrupted would result if the amount of fat stored in gut granules was minor relative to the overall level of fat in the animal. Alternatively, the loss of gut granules might result in the redistribution of fat to other cells types. In both cases, fat outside the gut granule would not be visible by Nile Red staining, as the glo mutants do not contain obvious staining with this dye elsewhere in the animal.Plant and animals cells store fat in lipid droplets (Murphy, 2001 ), organelles that are structurally and functionally distinct from gut granules. Gut granules are lysosome-related organelles that are surrounded by a lipid bilayer (Leung et al., 1999 ), act as terminal endocytic compartments (Clokey and Jacobson, 1986 ), and have an acidic lumen due to the activity of the V-ATPase (Oka and Futai, 2000 ). In contrast, lipid droplets do not have a vesicular structure and instead are composed of fatty acids, sterols, and embedded proteins surrounded by a phospholipid monolayer (Murphy, 2001 ). PAT family proteins specifically associate with lipid droplets in mammalian and Drosophila cells and are essential regulators of lipid droplet biogenesis, homeostasis, and movement (Murphy, 2001 ; Martin and Parton, 2005 ; Welte et al., 2005 ). Genes encoding members of the PAT family are broadly conserved, being found in Dictyostelium, Drosophila, and vertebrates; however, they appear to be lacking from the C. elegans genome (Lu et al., 2001 ). This raises the possibility that lipid droplets are not generated in C. elegans, which would represent a significant mechanistic variation in fat metabolism between C. elegans and other systems.Although lysosomes are major sites of lipid degradation in eukaryotic cells, fat is typically not found in significant quantities in lysosomes because of the rapid export of the products generated during lipid catabolism (Kolter and Sandhoff, 2005 ). However, there are a few exceptional cases where lysosomes contain a greatly increased amount of fat. Human genetic diseases including Tay-Sachs and Niemann-Pick result from defective lipid degradation in/or lipid trafficking from lysosomes (Maxfield and Tabas, 2005 ). Lamellar bodies are fat containing lysosome-related organelles that function in the synthesis and secretion of lung surfactant (Weaver et al., 2002 ). It remains to be seen whether the pathways leading to lysosomal fat accumulation in these cases resemble the pathways by which fat accumulates in C. elegans gut granules. Further studies of gut granules formation and function should enhance our understanding of the lysosomal processes involved in regulating fat transport and metabolism.ACKNOWLEDGMENTS We thank members of the Hermann, Binford, Lycan, and Reiness labs for advice and helpful discussions. We thank Marc Hammarlund for SNP mapping discussions, methods, and primer sequences. We gratefully acknowledge Masamitsu Futai, Kenji Kontani, Renaud Legouis, and Joel Rothman for gifts of antisera and Barth Grant for C. elegans vectors and strains. Some nematode strains were provided by the Caenorhabditis Genetics Center, the C. elegans Knockout Consortium, and the National Bioresource Project for C. elegans. This work was supported by grants from the National Science Foundation (MCB-0314332) to G.J.H. and the National Institutes of Health (R01-DK074114) to J.L.W. Footnotes This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E06-08-0685) on January 3, 2007. REFERENCES
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||||
Annu Rev Cell Biol. 1989; 5():483-525.
[Annu Rev Cell Biol. 1989]FASEB J. 2000 Jul; 14(10):1265-78.
[FASEB J. 2000]Trends Genet. 1999 Sep; 15(9):337-40.
[Trends Genet. 1999]Traffic. 2002 Apr; 3(4):237-48.
[Traffic. 2002]Semin Cell Dev Biol. 2002 Aug; 13(4):293-302.
[Semin Cell Dev Biol. 2002]Science. 2004 Jul 2; 305(5680):55-9.
[Science. 2004]Pigment Cell Res. 2002 Dec; 15(6):405-19.
[Pigment Cell Res. 2002]Bioessays. 2004 Jun; 26(6):616-28.
[Bioessays. 2004]Pigment Cell Res. 2006 Feb; 19(1):19-42.
[Pigment Cell Res. 2006]Curr Opin Cell Biol. 2004 Aug; 16(4):458-64.
[Curr Opin Cell Biol. 2004]Mech Ageing Dev. 1986 Jun; 35(1):79-94.
[Mech Ageing Dev. 1986]Mol Biol Cell. 2005 Jul; 16(7):3273-88.
[Mol Biol Cell. 2005]Int J Dev Biol. 1996 Feb; 40(1):431-9.
[Int J Dev Biol. 1996]Cell. 1980 Mar; 19(3):569-77.
[Cell. 1980]Biochem Biophys Res Commun. 2005 Dec 16; 338(2):862-71.
[Biochem Biophys Res Commun. 2005]Nature. 2003 Jan 16; 421(6920):268-72.
[Nature. 2003]Genetics. 1974 May; 77(1):71-94.
[Genetics. 1974]Mol Biol Cell. 2001 Jul; 12(7):2011-21.
[Mol Biol Cell. 2001]Proc Natl Acad Sci U S A. 2004 Mar 30; 101(13):4483-8.
[Proc Natl Acad Sci U S A. 2004]Mol Biol Cell. 2005 Jul; 16(7):3273-88.
[Mol Biol Cell. 2005]Mol Biol Cell. 2005 Jul; 16(7):3273-88.
[Mol Biol Cell. 2005]BMC Genomics. 2005 Sep 12; 6():118.
[BMC Genomics. 2005]Nature. 2003 Jan 16; 421(6920):231-7.
[Nature. 2003]Curr Biol. 2002 Aug 6; 12(15):1317-9.
[Curr Biol. 2002]Mol Biol Cell. 2005 Jul; 16(7):3273-88.
[Mol Biol Cell. 2005]Nature. 2003 Jan 16; 421(6920):268-72.
[Nature. 2003]Dev Cell. 2005 May; 8(5):787-94.
[Dev Cell. 2005]J Biol Chem. 2000 Sep 22; 275(38):29556-61.
[J Biol Chem. 2000]Traffic. 2005 Aug; 6(8):695-705.
[Traffic. 2005]PLoS Genet. 2006 Jul; 2(7):e108.
[PLoS Genet. 2006]Biotechniques. 2002 Apr; 32(4):728-30.
[Biotechniques. 2002]Mol Biol Cell. 2006 Mar; 17(3):1286-97.
[Mol Biol Cell. 2006]Genetics. 1995 Nov; 141(3):977-88.
[Genetics. 1995]Genome Biol. 2004; 5(3):R15.
[Genome Biol. 2004]Cell Mol Life Sci. 2004 Mar; 61(6):682-99.
[Cell Mol Life Sci. 2004]Mol Biol Cell. 2005 Jul; 16(7):3273-88.
[Mol Biol Cell. 2005]Dev Biol. 1983 Nov; 100(1):64-119.
[Dev Biol. 1983]Mol Biol Cell. 2005 Jul; 16(7):3273-88.
[Mol Biol Cell. 2005]Dev Cell. 2005 May; 8(5):787-94.
[Dev Cell. 2005]J Biol Chem. 2000 Sep 22; 275(38):29556-61.
[J Biol Chem. 2000]Mol Biol Cell. 2006 Mar; 17(3):1286-97.
[Mol Biol Cell. 2006]Mol Biol Cell. 2005 Jul; 16(7):3273-88.
[Mol Biol Cell. 2005]Mol Biol Cell. 2005 Jul; 16(7):3273-88.
[Mol Biol Cell. 2005]Nat Cell Biol. 2001 Jun; 3(6):573-9.
[Nat Cell Biol. 2001]Mol Biol Cell. 2006 Mar; 17(3):1286-97.
[Mol Biol Cell. 2006]Traffic. 2005 Aug; 6(8):695-705.
[Traffic. 2005]Mol Biol Cell. 2005 Jul; 16(7):3273-88.
[Mol Biol Cell. 2005]Mol Biol Cell. 2001 Jul; 12(7):2011-21.
[Mol Biol Cell. 2001]Mech Ageing Dev. 1986 Jun; 35(1):79-94.
[Mech Ageing Dev. 1986]Biochem Biophys Res Commun. 2005 Dec 16; 338(2):862-71.
[Biochem Biophys Res Commun. 2005]Genome Biol. 2004; 5(3):R15.
[Genome Biol. 2004]Mol Biol Cell. 2005 Jul; 16(7):3273-88.
[Mol Biol Cell. 2005]Mol Biol Cell. 2001 Oct; 12(10):2907-20.
[Mol Biol Cell. 2001]Nature. 2003 Jan 16; 421(6920):268-72.
[Nature. 2003]Biochem Biophys Res Commun. 2005 Dec 16; 338(2):862-71.
[Biochem Biophys Res Commun. 2005]Dev Cell. 2003 Jan; 4(1):131-42.
[Dev Cell. 2003]Cytometry. 1994 Oct 1; 17(2):151-8.
[Cytometry. 1994]Nature. 2003 Jan 16; 421(6920):268-72.
[Nature. 2003]J Mol Biol. 2004 Nov 19; 344(2):409-17.
[J Mol Biol. 2004]Biochem Biophys Res Commun. 2005 Dec 16; 338(2):862-71.
[Biochem Biophys Res Commun. 2005]J Biol Chem. 2001 Apr 13; 276(15):11913-21.
[J Biol Chem. 2001]Genetics. 1995 Nov; 141(3):977-88.
[Genetics. 1995]FEMS Microbiol Rev. 1998 Apr; 22(1):1-20.
[FEMS Microbiol Rev. 1998]Mol Cell Biol. 1989 Dec; 9(12):5289-97.
[Mol Cell Biol. 1989]Biochemistry. 1998 Mar 31; 37(13):4592-602.
[Biochemistry. 1998]EMBO J. 1991 Dec; 10(12):3777-85.
[EMBO J. 1991]Mech Ageing Dev. 1986 Jun; 35(1):79-94.
[Mech Ageing Dev. 1986]Mol Biol Cell. 2005 Jul; 16(7):3273-88.
[Mol Biol Cell. 2005]Annu Rev Cell Biol. 1989; 5():483-525.
[Annu Rev Cell Biol. 1989]Bioessays. 2001 Apr; 23(4):333-43.
[Bioessays. 2001]J Biol Chem. 2000 Sep 22; 275(38):29556-61.
[J Biol Chem. 2000]Biochem Biophys Res Commun. 2005 Dec 16; 338(2):862-71.
[Biochem Biophys Res Commun. 2005]J Cell Sci. 2000 Jul; 113 ( Pt 14)():2595-606.
[J Cell Sci. 2000]Mol Biol Cell. 2006 Mar; 17(3):1286-97.
[Mol Biol Cell. 2006]Annu Rev Cell Biol. 1992; 8():67-113.
[Annu Rev Cell Biol. 1992]Mol Cell Biol. 1989 Dec; 9(12):5289-97.
[Mol Cell Biol. 1989]Biochemistry. 1998 Mar 31; 37(13):4592-602.
[Biochemistry. 1998]EMBO J. 1991 Dec; 10(12):3777-85.
[EMBO J. 1991]Annu Rev Biochem. 2002; 71():537-92.
[Annu Rev Biochem. 2002]Biochim Biophys Acta. 2005 Mar 21; 1733(1):29-52.
[Biochim Biophys Acta. 2005]FEBS Lett. 2006 Feb 13; 580(4):1171-7.
[FEBS Lett. 2006]Trends Cell Biol. 2005 May; 15(5):259-68.
[Trends Cell Biol. 2005]Nature. 2005 Dec 1; 438(7068):612-21.
[Nature. 2005]N Engl J Med. 2004 Mar 25; 350(13):1296-303.
[N Engl J Med. 2004]J Biol Chem. 2006 Apr 7; 281(14):9791-800.
[J Biol Chem. 2006]Semin Cell Dev Biol. 2002 Aug; 13(4):263-70.
[Semin Cell Dev Biol. 2002]J Cell Sci. 2001 Nov; 114(Pt 21):3923-32.
[J Cell Sci. 2001]J Biol Chem. 2001 Oct 19; 276(42):39476-83.
[J Biol Chem. 2001]J Lipid Res. 1985 Jul; 26(7):781-9.
[J Lipid Res. 1985]J Cell Biol. 1985 Mar; 100(3):965-73.
[J Cell Biol. 1985]Cytometry. 1994 Oct 1; 17(2):151-8.
[Cytometry. 1994]Mol Biol Cell. 2005 Jul; 16(7):3273-88.
[Mol Biol Cell. 2005]Nature. 2003 Jan 16; 421(6920):268-72.
[Nature. 2003]Nature. 2006 Aug 10; 442(7103):700-4.
[Nature. 2006]Mol Biol Cell. 2005 Jul; 16(7):3273-88.
[Mol Biol Cell. 2005]Prog Lipid Res. 2001 Sep; 40(5):325-438.
[Prog Lipid Res. 2001]Dev Biol. 1999 Dec 1; 216(1):114-34.
[Dev Biol. 1999]Mech Ageing Dev. 1986 Jun; 35(1):79-94.
[Mech Ageing Dev. 1986]J Biol Chem. 2000 Sep 22; 275(38):29556-61.
[J Biol Chem. 2000]Semin Cell Dev Biol. 2005 Apr; 16(2):163-74.
[Semin Cell Dev Biol. 2005]Annu Rev Cell Dev Biol. 2005; 21():81-103.
[Annu Rev Cell Dev Biol. 2005]Nature. 2005 Dec 1; 438(7068):612-21.
[Nature. 2005]Semin Cell Dev Biol. 2002 Aug; 13(4):263-70.
[Semin Cell Dev Biol. 2002]Curr Biol. 2002 Aug 6; 12(15):1317-9.
[Curr Biol. 2002]